A systematic review of injecting-related injury and disease among people who inject drugs

S Larney, A Peacock, BM Mathers, M Hickman… - Drug and alcohol …, 2017 - Elsevier
Background Non-viral injecting-related injuries and diseases (IRID), such as abscesses and
vascular damage, can result in significant morbidity and mortality if untreated. There has …

Buprenorphine vs methadone treatment: A review of evidence in both developed and develo** worlds

PJ Whelan, K Remski - Journal of neurosciences in rural …, 2012 - thieme-connect.com
Heroin dependence is a major health and social problem associated with increased
morbidity and mortality that adversely affects social circumstances, productivity, and …

[LIBRO][B] Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence

World Health Organization. Department of Mental … - 2009 - books.google.com
These Guidelinesreview the use of medicines such as methadone, buprenorphine,
naltrexone and clonidine in combination with psychosocial support in the treatment of …

Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review

M A. Yokell, N D. Zaller, T C. Green… - Current drug abuse …, 2011 - benthamdirect.com
The diversion, misuse, and non-medically supervised use of buprenorphine and
buprenorphine/naloxone by opioid users are reviewed. Buprenorphine and buprenorphine …

Pharmacologic treatments for opioid dependence: detoxification and maintenance options

HD Kleber - Dialogues in clinical neuroscience, 2007 - Taylor & Francis
While opioid dependence has more treatment agents available than other abused drugs,
none are curative. They can, however, markedly diminish withdrawal symptoms and craving …

Abuse liability of buprenorphine–naloxone tablets in untreated IV drug users

H Alho, D Sinclair, E Vuori, A Holopainen - Drug and alcohol dependence, 2007 - Elsevier
Buprenorphine (Subutex®) is widely abused in Finland. A combination of buprenorphine
plus naloxone (Suboxone®) has been available since late 2004, permitting a comparison of …

Definitions related to the use of pharmaceutical opioids: Extramedical use, diversion, non‐adherence and aberrant medication‐related behaviours

B Larance, L Degenhardt, N Lintzeris… - Drug and alcohol …, 2011 - Wiley Online Library
Aims. This paper (i) reviews the language used to describe and manage those patient
practices that fall outside standard medical models of opioid treatment (for pain and opioid …

Effect of buprenorphine dose on treatment outcome

A Fareed, S Vayalapalli, J Casarella… - Journal of addictive …, 2012 - Taylor & Francis
The goal of this meta-analysis is to provide evidence based information about proper dosing
for buprenorphine maintenance treatment to improve treatment outcome. To be selected for …

[HTML][HTML] Monitoring medication and illicit drug consumption in a prison by wastewater-based epidemiology: Impact of COVID-19 restrictions

Z Wang, JF Mueller, JW O'Brien, J Thompson… - Water Research, 2023 - Elsevier
Drug consumption in prisons is a concern for the safety of incarcerated people and staff.
Typically, drug use prevalence in prisons is estimated through urinalysis and intelligence …

Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine‐maintained intravenous heroin abusers

SD Comer, MA Sullivan, SK Vosburg, J Manubay… - …, 2010 - Wiley Online Library
Background Sublingual buprenorphine is an effective maintenance treatment for opioid
dependence, yet intravenous buprenorphine misuse occurs. A buprenorphine/naloxone …